Clonal hematopoiesis in large granular lymphocytic leukemia.

Autor: Kawashima N; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Gurnari C; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.; Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy., Bravo-Perez C; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.; Department of Hematology and Medical Oncology, Hospital Universitario Morales Meseguer, University of Murcia, IMIB-Pascual Parrilla, CIBERER - Instituto de Salud Carlos III, Murcia, Spain., Kubota Y; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.; Department of Pediatrics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan., Pagliuca S; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.; Department of Clinical Hematology, CHRU de Nancy, Nancy, France., Guarnera L; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.; Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy., Williams ND; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Durmaz A; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Ahmed A; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Dima D; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Ullah F; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Carraway HE; Department of Hematology Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Singh A; Department of Hematology Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Visconte V; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Maciejewski JP; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA. maciejj@ccf.org.

Publikováno v: Leukemia [Leukemia] 2024 Nov 21. Date of Electronic Publication: 2024 Nov 21.

Context-dependent role of trisomy 6 in myelodysplastic neoplasms and acute myeloid leukemia: a multi-omics analysis.

Autor: Awada H; Department of Translational Hematology and Oncology Research, Cleveland Clinic, Cleveland, OH, USA., Durmaz A; Department of Translational Hematology and Oncology Research, Cleveland Clinic, Cleveland, OH, USA., Kewan T; Yale Cancer Center, New Haven, CT, USA., Ullah F; Department of Translational Hematology and Oncology Research, Cleveland Clinic, Cleveland, OH, USA., Dima D; Department of Translational Hematology and Oncology Research, Cleveland Clinic, Cleveland, OH, USA., Awada H; Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Pagliuca S; Department of Clinical Hematology, CHRU de Nancy, Nancy, France., Meggendorfer M; MLL Munich Leukemia Laboratory, Munich, Germany., Haferlach T; MLL Munich Leukemia Laboratory, Munich, Germany., Gurnari C; Department of Translational Hematology and Oncology Research, Cleveland Clinic, Cleveland, OH, USA.; Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy., Visconte V; Department of Translational Hematology and Oncology Research, Cleveland Clinic, Cleveland, OH, USA., Maciejewski JP; Department of Translational Hematology and Oncology Research, Cleveland Clinic, Cleveland, OH, USA. maciejj@ccf.org.

Publikováno v: Leukemia [Leukemia] 2024 Jun; Vol. 38 (6), pp. 1411-1414. Date of Electronic Publication: 2024 May 11.

Current Opinions on the Clinical Utility of Ravulizumab for the Treatment of Paroxysmal Nocturnal Hemoglobinuria

Autor: Gurnari C, Nautiyal I, Pagliuca S

Publikováno v: Therapeutics and Clinical Risk Management, Vol Volume 17, Pp 1343-1351 (2021)

Carmelo Gurnari,1,2 Ishani Nautiyal,1 Simona Pagliuca1,3 1Department of Translational Hematology and Oncology Research, Taussig Cancer Center, Cleveland Clinic Foundation, Cleveland, OH, USA; 2Department of Biomedicine and Prevention, PhD in Immunolo

Externí odkaz: https://doaj.org/article/e616c55bc21a41a68a22f9b90720a07f

Role of molecular alterations in transplantation decisions for patients with primary myelofibrosis.

Autor: Luque Paz D; Univ Angers, Nantes Université, CHU Angers, Inserm, CNRS, CRCI2NA, F-49000, Angers, France, ANGERS, France., Gagelmann N; University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Benajiba L; Université Paris Cité, APHP, Hôpital Saint-Louis, INSERM U944, Paris, France., Riou J; MINT UMR INSERM 1066, UMR CNRS 6021, ANGERS, France., Salit RB; Fred Hutchinson Cancer Research Center, Seattle, Washington, United States., Orvain C; Angers University Hospital, Angers, France., Schroeder T; University Hospital Essen, Essen, Germany., Bories C; CH Lens, Lens, France., Gurnari C; Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, United States., Badbaran A; Bone Marrow Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany, hamburg, Germany., Boyer-Perrard F; CHU d'Angers., Pagliuca S; Centre Hospitalier Régional Universitaire de Nancy, Vandœuvre-lès-Nancy, France., Rautenberg C; University Hospital Essen, Essen, Germany., Tavitian S; Institut Universitaire du Cancer de Toulouse Oncopole, France, France., Panagiota V; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany, Hannover, Germany., Ianotto JC; Brest University Hospital, Brest, France., Thol FR; Hannover Medical School, Hannover, Germany., Cayssials E; INSERM and CHU of Poitiers, Poitiers, France., Heuser M; Hannover Medical School, Hannover, Germany., Rubio MT; CHRU Nancy, Vandoeuvre les Nancy, France., Cassinat B; Hopital Saint-Louis, Assistance Publique-Hopitaux de Paris, Paris, France., Daltro de Oliveira R; Université de Paris, APHP, Hôpital Saint-Louis, Paris, France., Sauter CS; Cleveland Clinic, Cleveland, Ohio, United States., Maciejewski JP; Cleveland Clinic, Cleveland, Ohio, United States., Reinhardt HC; University Hospital Cologne, Essen, Germany., Scott BL; Fred Hutchinson Cancer Research Center, Seattle, Washington, United States., Ugo V; CHU ANGERS, Angers, France., Kröger N; University Medical Center Hamburg_Eppendorf, Hamburg, Germany., Kiladjian JJ; Hôpital Saint-Louis AP-HP & Université Paris Cité, Paris, France., Robin M; Hopital Saint Louis, Paris, France.

Publikováno v: Blood advances [Blood Adv] 2024 Nov 19. Date of Electronic Publication: 2024 Nov 19.

Anti-T-lymphocyte globulin improves GvHD-free and relapse-free survival in myelofibrosis after matched related or unrelated donor transplantation.

Autor: Rathje K; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Gagelmann N; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Salit RB; Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Schroeder T; Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital of Essen, Essen, Germany., Gurnari C; Translational Hematology and Oncology Research Department, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA.; Department of Biomedicine and Prevention, Tor Vergata University of Rome, Rome, Italy., Pagliuca S; Department of Hematology, Nancy University Hospital, and UMR 7365, University of Lorraine, Vandoeuvre-lès-Nancy, France., Panagiota V; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany., Rautenberg C; Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital of Essen, Essen, Germany., Cassinat B; APHP, Laboratoire de biologie cellulaire, Hôpital Saint-Louis, Paris, France., Thol F; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany., Robin M; Service d'Hématologie-Greffe, Hôpital Saint-Louis, Assistance Publique Hôpitaux de Paris, Paris, France., Oechsler S; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Heuser M; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany., Rubio MT; Department of Hematology, Nancy University Hospital, and UMR 7365, University of Lorraine, Vandoeuvre-lès-Nancy, France., Maciejewski JP; Translational Hematology and Oncology Research Department, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA., Reinhardt HC; Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital of Essen, Essen, Germany., Scott BL; Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Kröger N; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. nkroeger@uke.uni-hamburg.de.

Publikováno v: Bone marrow transplantation [Bone Marrow Transplant] 2024 Aug; Vol. 59 (8), pp. 1154-1160. Date of Electronic Publication: 2024 May 21.